Is Oramed Pharmaceuticals Inc. (ORMP) a Buy, Sell, or Hold?
NASDAQ : ORMP
Oramed Pharmaceuticals Inc. — Institutional Ownership
$4.25 USD
$0.05 (1.19%)
- Volume
- 159.36K
- Average Volume
- 247.48K
- Market Capitalization
- $173.94M
- P/E Ratio
- 1.00
- Dividend Yield
- 5.88%
- Price Target
- Year High
- $5.19
- Year Low
- $1.98
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.05
- Current Ratio
- $4.98
Institutional Ownership Summary
Institutional Ownership %
%
Investors Holding
change: 0.0 | last:
Increased Positions
change: 0.0 | last:
Reduced Positions
change: 0.0 | last:
New Positions
change: 0.0 | last:
Sold Positions
change: 0.0 | last:
Total Calls
-
Total Puts
-
Put-Call Ratio
change: 0.0 | last:
Total Invested
-
Beneficial Ownership Filings
| Filing Date | Reporting Person | Amount Beneficially Owned | % of Class |
|---|---|---|---|
| 2026-07-22 | Oramed Pharmaceuticals Inc. | 6.88M | 3.30% |
| 2026-06-29 | BML Investment Partners, L.P. | 866.27K | 2.10% |
| 2026-06-17 | Oramed Pharmaceuticals Inc. | 15.08M | 7.20% |
| 2026-05-15 | Aquamarine Financial (Cayman) Ltd | 2.05M | 5.06% |
| 2026-05-14 | Oramed Pharmaceuticals Inc. | 1.53M | 49.90% |
| 2026-02-19 | Oramed Pharmaceuticals Inc. | 10.94M | 5.20% |
| 2026-02-13 | Oramed Pharmaceuticals Inc. | 437.51K | 4.90% |
| 2026-02-09 | BML Investment Partners, L.P. | 3.17M | 7.90% |
| 2026-01-29 | Nadav Kidron | 10.55M | 5.00% |
| 2026-01-29 | Oramed Pharmaceuticals Inc. | 10.41M | 5.00% |
| 2025-11-14 | Oramed Pharmaceuticals Inc. | 833.47K | 9.90% |
| 2025-08-28 | Nadav Kidron | 3.12M | 7.60% |
| 2025-08-14 | Oramed Pharmaceuticals Inc. | 764.28K | 9.90% |
| 2025-05-08 | Oramed Pharmaceuticals Inc. | 732.72K | 9.90% |
| 2025-05-01 | Oramed Pharmaceuticals Inc. | 14.11M | 19.99% |
| 2025-05-01 | Oramed Ltd. | 14.11M | 19.99% |
| 2025-02-13 | BML Investment Partners, L.P. | 2.64M | 6.55% |
| 2025-01-17 | Oramed Pharmaceuticals Inc. | 15.5M | 6.20% |
| 2024-09-16 | BML Investment Partners, L.P. | 2.05M | 5.00% |
| 2024-03-22 | Nadav Kidron | 2.34M | 5.70% |
| 2021-02-09 | David M. Slager | 1.34M | 5.04% |
| 2021-02-09 | Regals Fund LP | 1.34M | 5.04% |
| 2021-02-09 | Regals Capital Management LP | 1.34M | 5.04% |
| 2020-02-11 | Regals Fund LP | 1.32M | 7.40% |
| 2020-02-11 | David M. Slager | 1.32M | 7.40% |
| 2020-02-11 | Regals Capital Management LP | 1.32M | 7.40% |
| 2019-02-13 | Altium Capital Management, LP | 972K | 4.99% |
| 2019-02-13 | Altium Growth Fund, LP | 972K | 4.99% |
| 2019-02-13 | Altium Growth GP, LLC | 972K | 4.99% |
| 2018-07-13 | Altium Capital Growth GP, LLC | 972K | 5.61% |
| 2018-07-13 | Altium Growth Fund, LP | 972K | 5.61% |
| 2018-07-13 | Altium Capital Management, LP | 972K | 5.61% |
| 2018-07-12 | Steven Boyd | 856.43K | 4.90% |
| 2018-07-12 | Armistice Capital, LLC | 856.43K | 4.90% |
| 2018-07-12 | Armistice Capital Master Fund Ltd. | 856.43K | 4.90% |
| 2018-07-03 | VANGUARD SPECIALIZED FUNDS - VANGUARD REIT INDEX FUND | 2.78M | 5.01% |
| 2016-02-16 | Regals Capital Management LP | 1.88M | 15.90% |
| 2014-12-15 | Leonard Sank | 571.44K | 5.20% |
| 2014-02-06 | Prudential Financial, Inc. | - | 12.00% |
| 2014-02-06 | Prudential Financial, Inc. | 12.79M | 12.00% |
| 2013-12-31 | BARCLAYS GLOBAL INVESTORS, NA. | 1.98M | 2.61% |
| 2013-02-11 | Miriam Kidron | 469.11K | 6.10% |
| 2013-02-05 | Zeev Bronfeld | 697.18K | 9.60% |
| 2012-01-19 | Zeev Bronfeld | 6.76M | 9.59% |
| 2011-01-19 | Franklin Resources, Inc. | 3.57M | 6.50% |
| 2005-08-24 | Anthony Cheung | 990K | 11.00% |
| 2005-08-01 | Mark McLean | 1.48M | 11.00% |
| 2005-07-21 | Trevor Sali | 1.14M | 11.00% |
| 2005-07-20 | Jeremy Ross | 990K | 11.00% |
ORMP Enterprise Value History
Annual
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2025-12-31 | $2.85 | 41.4M | $118M | $45.95M | $825K | $72.88M |
| 2024-12-31 | $2.42 | 40.83M | $98.8M | $54.42M | $372K | $44.76M |
| 2023-12-31 | $2.31 | 40.32M | $93.13M | $9.06M | $51.62M | $135.69M |
| 2022-12-31 | $12.03 | 39M | $469.14M | $40.46M | $894K | $429.57M |
| 2021-08-31 | $19.68 | 28.47M | $560.27M | $77.24M | $533K | $483.56M |
| 2020-08-31 | $3.49 | 20.53M | $71.66M | $19.3M | $75000 | $52.44M |
| 2019-08-31 | $3.32 | 17.45M | $57.95M | $3.33M | -$ | $54.62M |
| 2018-08-31 | $4.95 | 14.88M | $73.67M | $5M | -$ | $68.67M |
| 2017-08-31 | $8.65 | 13.31M | $115.13M | $3.97M | -$ | $111.16M |
| 2016-08-31 | $7.21 | 12.62M | $91.02M | $3.91M | -$ | $87.11M |
Quarterly
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4.81 | 41.04M | $197.4M | $15.24M | $733K | $182.89M |
| 2026-03-31 | $3.40 | 40.77M | $138.63M | $13.2M | $761K | $126.19M |
| 2025-12-31 | $2.85 | 41.4M | $118M | $45.95M | $825K | $72.88M |
| 2025-09-30 | $2.64 | 41.76M | $110.24M | $52.18M | $860K | $58.92M |
| 2025-06-30 | $2.25 | 41.74M | $93.92M | $15.8M | $912K | $79.04M |
| 2025-03-31 | $2.14 | 41.23M | $88.23M | $74.52M | $301K | $14.01M |
| 2024-12-31 | $2.42 | 39.92M | $96.61M | $54.42M | $372K | $42.56M |
| 2024-09-30 | $2.44 | 40.9M | $99.79M | $42.1M | $429K | $58.11M |
| 2024-06-30 | $2.56 | 40.96M | $104.86M | $84.75M | $486K | $20.59M |
| 2024-03-31 | $2.83 | 40.84M | $115.57M | $18.58M | $32.56M | $129.55M |
| 2023-12-31 | $2.31 | 40.38M | $93.28M | $9.06M | $51.62M | $135.85M |
| 2023-09-30 | $2.61 | 40.45M | $105.56M | $5.47M | $76M | $176.1M |